3B Blackbio DX Ltd Financials
Company Logo

3B Blackbio DX Ltd Financial Statement

3B Blackbio DX Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue27.93
Operating Expense13.56
Net Profit9.24
Net Profit Margin33.08
Earning Per Share10.79
EBIDTA12.85
Effective Tax Rate23.52

3B Blackbio DX Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual70.72
Operating Expenses Annual35.62
Operating Profit Annual47.43
Interest Annual0.11
Depreciation0.87
Net Profit Annual34.21
Tax Annual12.23

3B Blackbio DX Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning50.35
Cash Flow from Operations28.47
Cash Flow from Investing-20.32
Cash Flow from Financing-3.62
Cash Flow at the End54.88

3B Blackbio DX Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)67.05
PBIT Margin (%)65.82
PBT Margin (%)-532.57
Net PROFIT Margin (%)48.37
Return On Networth / Equity (%)16.14
Return On Networth /Employed (%)21.82
Return On Assets (%)15.96
Total Debt / Equity (X)0.01
Asset Turnover Ratio (%)0.33

3B Blackbio DX Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual6.53
Total Current Assets Annual115.59
Non Current Assets Annual134.23
Total Shareholders Funds Annual227.78
Total Assets Annual249.82

3B Blackbio DX Ltd Earning Calls

EPS (INR)

Expected

9.80

Reported

9.38

Surprise

-4.29%

Dec 2024

EPS beaten by -4.29%

Sep 2024

EPS beaten by 0.70%

Jun 2024

EPS beaten by 1.52%

FAQS on 3B Blackbio DX Ltd Financials

As of Jun 19, 2025, 3B Blackbio DX Ltd has a market capitalization of 1,387.60 Cr. Value Research classifies it as a Small-Cap company.

Yes, 3B Blackbio DX Ltd is with a debt-to-equity ratio of 0.00.

In FY 2024 , 3B Blackbio DX Ltd recorded a total revenue of approximately 90.53 Cr marking a significant milestone in the company's financial performance.

3B Blackbio DX Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.7% and 0.2% annually, respectively..

3B Blackbio DX Ltd's current PE ratio is 29.18.

3B Blackbio DX Ltd's ROCE averaged 20.7% from the FY ending March 2023 to 2025, with a median of 20.4%. It peaked at 23.4% in March 2025, reflecting strong capital efficiency over the period..

3B Blackbio DX Ltd's latest EBIT is Rs. 64.03 Cr, surpassing the average EBIT of Rs. 48.87 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions